Skip to content
Clinical Trials – home

Mitral valve prolapse Diagnostics

1 / 1 trials open to patients1 country

In short

Mitral valve prolapse is a common heart condition that often goes unnoticed, as many people experience no symptoms at all. When the mitral valve's flaps don't close as they should, doctors use a combination of physical exams, listening tests, and imaging to understand what's happening in your heart. The good news is that most people discover they have this condition during a routine checkup, and finding it early helps doctors monitor it and prevent complications.

Key points

  • Most people discover they have mitral valve prolapse during routine checkups when doctors hear a distinctive clicking sound through a stethoscope.
  • Echocardiography is the gold standard diagnostic test—it's painless, radiation-free, and provides detailed moving pictures of your heart valves in action.
  • Having mitral valve prolapse doesn't automatically mean you have symptoms or need treatment—many people live completely normal lives without any intervention.
  • Regular monitoring is important even when you feel fine, because the condition can sometimes progress to severe regurgitation that requires treatment.
  • Thickened valve leaflets visible on echocardiography are considered a high-risk feature requiring annual monitoring rather than checks every few years.
  • You no longer need antibiotics before dental work just because you have mitral valve prolapse—medical guidelines changed when research showed the practice wasn't beneficial.
  • Exercise stress tests and Holter monitors help doctors understand whether physical activity or intermittent rhythm problems are contributing to symptoms.
  • The prognosis for mitral valve prolapse is excellent for most people, especially with appropriate monitoring and timely intervention if the valve leak worsens.

Introduction: When to Seek Diagnostics

Mitral valve prolapse affects up to 3% of people, yet many live their entire lives without knowing they have it. Diagnostics for this condition are important because they help determine whether the valve is working properly or if it's causing blood to leak backward, a situation called mitral regurgitation—when blood flows the wrong way through the valve.

You should consider seeking diagnostic evaluation if you experience certain warning signs. These include a racing or irregular heartbeat, dizziness or lightheadedness, difficulty breathing especially during exercise or when lying flat, or persistent fatigue. Chest pain can also be a symptom worth investigating. However, it's important to understand that many people with mitral valve prolapse never experience any of these symptoms at all.

Healthcare providers often discover mitral valve prolapse during routine health checkups. If you have a family history of the condition, it's advisable to mention this to your doctor, as mitral valve prolapse can run in families. People with certain connective tissue disorders—conditions that affect the body's structural proteins—such as Marfan syndrome or Ehlers-Danlos syndrome are at higher risk and should undergo diagnostic evaluation even without symptoms.

Women are more commonly diagnosed with mitral valve prolapse than men, though men are more likely to develop severe mitral regurgitation. If you've had rheumatic fever in the past, or if you have conditions like Graves' disease, scoliosis, or certain types of muscular dystrophy, your doctor may recommend diagnostic tests to check your heart valves.

Classic Diagnostic Methods

Physical Examination and Heart Sounds

The journey to diagnosing mitral valve prolapse usually begins during a routine physical examination. When your doctor listens to your heart with a stethoscope—a process called cardiac auscultation—they may hear distinctive sounds that suggest the valve isn't working quite right. The most characteristic sound is a clicking noise that happens when the mitral valve flaps bulge backward into the heart's upper chamber.

This clicking sound occurs during the heart's contraction phase, which is why it's sometimes called a systolic click. If blood is leaking backward through the valve, your doctor may also hear a whooshing sound known as a heart murmur. The heart murmur is created by turbulent blood flow—imagine water flowing smoothly through a pipe versus water spraying through a crack. The abnormal flow creates the whooshing noise doctors can detect.

However, not everyone with mitral valve prolapse has these sounds. Some people with the condition have valves that still close tightly enough that no leak occurs, so there's no murmur. Others may have very mild symptoms that come and go. This is why additional diagnostic tests are often needed to confirm the diagnosis and assess how severe the condition is.

Echocardiography: The Gold Standard

The most useful and reliable test for diagnosing mitral valve prolapse is an echocardiogram, often called an "echo." This test uses sound waves—similar to how submarines use sonar to see underwater—to create moving pictures of your heart. The test is completely painless and doesn't involve any radiation, making it very safe.

During a standard echocardiogram, also called a transthoracic echocardiogram (TTE), a technician places a device called a transducer on your chest. This device sends sound waves through your chest wall to your heart. When the sound waves bounce back, a computer converts them into moving images that show your heart beating in real time. Doctors can see the mitral valve's flaps, watch how they move, and determine whether they're bulging backward when they shouldn't be.

The echocardiogram provides crucial information beyond just confirming the diagnosis. It shows whether blood is leaking backward and, if so, how much. This helps doctors classify the severity of the condition as mild, moderate, or severe. The test also reveals whether the heart's chambers are enlarging in response to the leak, which can indicate that the condition is progressing and may need treatment.

In some cases, doctors need more detailed images than a standard echocardiogram provides. When this happens, they may recommend a transesophageal echocardiogram (TEE). For this test, a small transducer is attached to the end of a thin, flexible tube. After numbing your throat, the doctor gently guides this tube down your esophagus—the tube that connects your mouth to your stomach. Because the esophagus sits right behind the heart, this position provides exceptionally clear images of the mitral valve.

Chest X-Ray

A chest X-ray creates a picture of your heart and lungs using a small amount of radiation. While it cannot diagnose mitral valve prolapse directly, it helps doctors see whether your heart has become enlarged. When the mitral valve leaks significantly over time, the heart's left side may grow larger as it works harder to pump blood. An enlarged heart on an X-ray can indicate that mitral regurgitation is severe enough to affect heart function.

Electrocardiogram (ECG or EKG)

An electrocardiogram is a quick, painless test that records the electrical activity of your heart. Small sticky patches called electrodes are placed on your chest, arms, and legs. These patches detect the tiny electrical signals that make your heart beat. A machine records these signals and prints them out as a series of wavy lines on paper.

While an ECG cannot directly diagnose mitral valve prolapse, it can detect complications related to the condition. For example, if mitral valve prolapse has led to irregular heart rhythms—called arrhythmias—the ECG will show abnormal patterns in the electrical signals. This information helps doctors understand whether the valve problem is affecting your heart's rhythm and whether you need treatment for this complication.

Exercise or Stress Tests

Sometimes it's unclear whether someone with mitral valve prolapse is truly free of symptoms or whether symptoms appear only during physical activity. In these cases, doctors may recommend an exercise test, also called a stress test. During this test, you walk on a treadmill or ride a stationary bike while medical staff monitor your heart with an ECG.

The exercise stress test serves several purposes. It helps determine whether physical activity triggers symptoms like shortness of breath or chest pain. It also shows how well your heart handles the increased workload of exercise. If you cannot exercise due to physical limitations, doctors can give you medications that make your heart work harder, mimicking the effect of exercise without requiring you to move.

Holter Monitor

Some heart rhythm problems don't happen all the time—they come and go unpredictably. To catch these intermittent issues, doctors may ask you to wear a small portable device called a Holter monitor. This device, which you wear for 24 hours or longer, continuously records your heart's electrical activity while you go about your normal daily activities. Later, doctors analyze the recording to see if any abnormal rhythms occurred during the monitoring period.

Cardiac Catheterization

Cardiac catheterization is not commonly used to diagnose mitral valve prolapse, but it may be helpful when other tests haven't provided clear answers. During this procedure, a doctor inserts a thin, flexible tube called a catheter into a blood vessel in your arm or leg and guides it to your heart. The catheter allows the doctor to measure pressures inside the heart chambers and inject dye that makes blood vessels visible on X-ray images.

This test is more invasive than the others mentioned, meaning it involves entering the body rather than just examining it from the outside. Because of this, doctors reserve cardiac catheterization for situations where they need very specific information that other tests cannot provide, such as when planning for heart valve surgery.

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or procedures to see if they work better than existing options. While the sources provided don't contain specific information about diagnostic criteria used to qualify patients for mitral valve prolapse clinical trials, it's worth understanding that research participation generally requires thorough diagnostic evaluation.

In general medical practice, qualifying for treatment of mitral valve prolapse—whether in clinical trials or standard care—requires documentation of the condition's severity. Echocardiography plays the central role in this assessment. According to treatment guidelines, certain measurements from echocardiograms indicate severe mitral regurgitation. These include a vena contracta width—the narrowest part of the blood leak—greater than 0.7 centimeters, a large area of leaking blood representing more than 40% of the left atrium, and specific calculations showing how much blood is flowing backward with each heartbeat.

Measurements of the heart's left ventricle are also crucial for determining when intervention is needed. The left ventricular ejection fraction (LVEF)—which measures what percentage of blood the left ventricle pumps out with each beat—helps doctors understand how well the heart is functioning despite the leaky valve. Similarly, the left ventricular end-systolic dimension (LVESD)—a measurement of the left ventricle's size at the end of its contraction—indicates whether the heart is enlarging due to the extra workload created by the leaking valve.

Prognosis and Survival Rate

Prognosis

The outlook for people with mitral valve prolapse is generally excellent. Most individuals with this condition have a benign prognosis, meaning they can expect to live normal, full lives without the condition causing significant health problems. For many people, mitral valve prolapse is a lifelong condition that doesn't affect their lifestyle or life expectancy in any way.

However, the prognosis depends largely on whether the prolapse leads to significant mitral regurgitation. When the valve remains tight enough to prevent substantial blood leakage, people typically experience no symptoms and require no treatment beyond occasional monitoring. In these cases, the condition truly is harmless and doesn't progress to cause problems.

For the smaller number of people who develop moderate to severe mitral regurgitation, the outlook depends on timely detection and appropriate treatment. Factors that affect disease progression include the degree of blood leakage, how quickly the leak worsens, and whether the heart's left ventricle begins to enlarge or lose its pumping strength. Regular follow-up with a cardiologist helps catch any progression early, which improves outcomes significantly.

People with mitral valve prolapse are at risk for certain complications, though these are uncommon. These include heart failure, which occurs when the heart can no longer pump blood effectively; infective endocarditis, a serious infection of the heart valves; atrial fibrillation, an irregular heart rhythm; and in rare cases, stroke or sudden cardiac death. The risk of these complications increases with the severity of mitral regurgitation.

Certain features place people at higher risk for developing complications. These include having thickened valve leaflets visible on echocardiography, male gender, older age, and the presence of significant mitral regurgitation. People with high-risk features require more frequent monitoring—typically annual echocardiograms—to detect any worsening of the condition early.

Survival rate

Specific survival statistics for mitral valve prolapse are not provided in the available sources. However, the sources consistently emphasize that mitral valve prolapse itself—when it doesn't cause significant regurgitation—is considered a benign condition that doesn't affect survival. Most people with mitral valve prolapse live completely normal lives with typical life expectancies.

For those who develop severe mitral regurgitation and require surgical intervention, modern mitral valve repair techniques have excellent success rates. Experienced centers report surgical mortality rates below 1% for mitral valve repair procedures. This means that more than 99 out of 100 people survive the surgery and typically experience significant improvement in symptoms and quality of life afterward.

The key to maintaining an excellent prognosis is regular follow-up care with a cardiologist who can monitor the condition over time. Early detection of worsening mitral regurgitation allows for timely surgical intervention before irreversible damage occurs to the heart. People who undergo valve repair before significant heart enlargement or loss of pumping function develops typically have better long-term outcomes than those whose surgery is delayed until more advanced stages of heart damage.

Did you know?

  1. Mitral valve prolapse was once blamed for symptoms like chest pain and palpitations, but research has shown that while people with MVP can have these symptoms, the valve condition is usually not their cause.[20]
  2. Antibiotics are no longer recommended before dental work for people with mitral valve prolapse. The American Heart Association changed this guideline because the risks of antibiotics outweigh the very small risk of developing a heart infection from dental procedures.[20]
  3. The clicking sound doctors hear through a stethoscope when diagnosing MVP occurs at the exact moment the valve flaps bulge backward—it's like hearing a tiny parachute pop open inside your heart.[5]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Mitral valve prolapse

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Flecainide
  • Sponsor:Oslo University Hospital HF
See all 1 trials →filters applied: condition = Mitral valve prolapse

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).